Next, in a separate cohort we investigated CD4+ T-cell responses to the five C-peptide variants with individual Q to E substitutions in PBMC of people with recent onset type 1 diabetes (Fig. 3B). This evidence concerns the gene CD4 and type 1 diabetes mellitus.